- Home
- CMPX vs CGC Comparison
CMPX vs CGC Comparison
Compare CMPX & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- CGC
- Stock Information
- Founded
- CMPX 2014
- CGC N/A
- Country
- CMPX United States
- CGC Canada
- Employees
- CMPX N/A
- CGC 960
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- CMPX Health Care
- CGC Health Care
- Exchange
- CMPX Nasdaq
- CGC Nasdaq
- Market Cap
- CMPX 291.8M
- CGC 311.8M
- IPO Year
- CMPX N/A
- CGC N/A
- Fundamental
- Price
- CMPX $2.97
- CGC $1.30
- Analyst Decision
- CMPX Strong Buy
- CGC Hold
- Analyst Count
- CMPX 8
- CGC 1
- Target Price
- CMPX $13.50
- CGC N/A
- AVG Volume (30 Days)
- CMPX 1.3M
- CGC 21.1M
- Earning Date
- CMPX 08-11-2025
- CGC 08-08-2025
- Dividend Yield
- CMPX N/A
- CGC N/A
- EPS Growth
- CMPX N/A
- CGC N/A
- EPS
- CMPX N/A
- CGC N/A
- Revenue
- CMPX N/A
- CGC $201,572,742.00
- Revenue This Year
- CMPX N/A
- CGC $2.45
- Revenue Next Year
- CMPX N/A
- CGC $3.66
- P/E Ratio
- CMPX N/A
- CGC N/A
- Revenue Growth
- CMPX N/A
- CGC N/A
- 52 Week Low
- CMPX $1.15
- CGC $0.77
- 52 Week High
- CMPX $4.08
- CGC $7.21
- Technical
- Relative Strength Index (RSI)
- CMPX 50.84
- CGC 51.99
- Support Level
- CMPX $2.66
- CGC $1.02
- Resistance Level
- CMPX $3.47
- CGC $1.81
- Average True Range (ATR)
- CMPX 0.25
- CGC 0.14
- MACD
- CMPX -0.02
- CGC 0.05
- Stochastic Oscillator
- CMPX 38.27
- CGC 36.48
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.